Label-free Array Systems Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028.

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,900	114 Pages	TechSci Research	August, 2023	TCSI18102253

Best Price Guarantee
Price	from $4,900
Length	114 Pages
Publisher	TechSci Research
Published Date	August, 2023
SKU	TCSI18102253

Label-free Array Systems Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028.

Segmented By Type (Surface Plasmon Resonance, Bio-layer Interferometry, Cellular Dielectric Spectroscopy, Others), By Application (Drug Discovery, Protein Interface Analysis, Antibody Characterization, Others), By End user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations, Others), By Region and Competition

Label-free Array Systems Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing demand for personalized medicines, rapid drug delivery, biomarker identification, identification of specific protein markers in specific diseases or conditions, and increased usage of Label-free Array Systems Market as a research tool in drug discovery.

Without the use of fluorescent or radioactive labels, label-free array systems are analytical tools that are utilized to identify and quantify biomolecules in complicated samples. These devices work on the concept of Surface Plasmon Resonance (SPR), which enables the measurement of biomolecule binding to the array surface as well as changes in the reflected light.

Moreover, Label-free array systems are advantageous as there is no need for the use of hazardous or costly labeling agents, which makes them a safer and more affordable substitute compared to conventional labeling techniques. Label-free array devices can be used to analyze biomolecule interactions in real-time without the use of fluorescence or radioactivity, providing dynamic and quantitative data about the interacting molecules.

Increasing Demand for Personalized Medicine

In recent times, modern medicines are gradually moving towards precision medicine to eliminate individual dose dismissal. Label-free array systems eliminate the requirement for dyes, reagents, modified cells, and tags while providing data that is extremely sensitive for an endogenous target in live cell experiments. Techniques such as Interference-based Surface Plasmon Resonance (SPR), Scanning Kelvin Nanoprobe, Atomic Force Microscopy, etc., are utilized in label-free detection. Furthermore, installing even a few of the thousands of potential diagnostic biomarkers identified each year as part of personalized treatment workflows necessitates clinically efficient biosensor technologies to monitor multiple biomarkers in patients in real-time. In this way, the label-free array system is of great importance and is thereby adding to support the market growth driving personalized medicine demand.

Growing Demand for Label-Free Array Systems in Biomedical System

The growing demand for label-free array systems is highly observed in biomedical medicines along with biological sciences. Advancements and update in science, nanotechnology, and integrated computational configuration are promoting the development of label-free array systems such as microarrays, label-free biosensor arrays, etc. These microarray, label-free biosensor techniques are helpful in getting efficient clarity of- disease signaling pathways, biomarker screening, drug discovery, protein profiling, drug target identification, etc., and are therefore aiding the diagnostic process, which is further adding to the market demand by propelling the market growth. Also, Manufacturers are focusing on developing efficient and accurate readout systems and cellular models with respect to launching mechanisms and functional studies on cellular and molecular levels.

Rising Focus on Drug Delivery Efficiency

Based on the Label-Free Array Systems and patient samples, the leading market players are generating biorelevant data, which further helps in improved drug development. The Label-free methods, like detection and measurement of a local change in refractive index, are utilized for studying distinct interactions comprising Leading market players are producing biorelevant data using Label-Free Array Systems and patient samples, which further aids in improved medication development drug molecules and their receptors. For instance, Mass Spectroscopy is utilized as a label-free approach to drug delivery. For Instance, scientists from Merck matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to peptides to identify their absorption, distribution, metabolism, and excretion (ADME) properties, thereby increasing the market growth with the rise in utilization for drug delivery practices.

Growing demand for Atomic Force Spectroscopy

Atomic Force Microscopy (AFM) is in high demand due to its advanced applications, including diagnosis and carrying cancer research. The applications of AFM to carry crucial operations on cells, moreover, in physiological setups, help in the study of the mechanical characteristics of the living cells. Also, Atomic Force Microscopy (AFM) includes the involvement of minimum sample manipulation and is, therefore, an efficient tool for the research and study of biological materials such as bacteria, DNA, cells, and viruses in their native environments. Hence, the market demand for label-free array systems is enhanced by the utilization of AFM to be employed as a high-resolution research tool to examine and identify the mechanical properties and ultrastructure of tumor cells.

Market Segmentation

Label-free Array Systems Market is segmented based on the type, application, end-user, and region. Based on type, the market is segmented into surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others. Based on application, the market is segmented into drug discovery, protein interface analysis, antibody characterization, and others. Based on end users, the market is further fragmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and others. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Sartorius AG, etc.., are some of the major players operating in the Global Label-free Array Systems Market.

Report Scope:

In this report, Global Label-free Array Systems Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Label-free Array Systems Market, By Type:
Surface Plasmon Resonance
Bio-layer Interferometry
Cellular Dielectric Spectroscopy
Others
Label-free Array Systems Market, By Mode:
Automated ELISA Analyzers
Semi-Automated Analyzers
Label-free Array Systems Market, By Application:
Drug Discovery
Protein Interface Analysis
Antibody Characterization
Others
Label-free Array Systems Market, By End User:
Pharmaceutical and Biotechnology Companies
Academic and Research Institute
Contract Research Organization
Others
Label-free Array Systems Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Asia-Pacific
China
Japan
India
South Korea
Australia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
South America
Brazil
Argentina
Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Label-free Array Systems Market.

Company Information

Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights

1. Product Overview: 1.1. Market Definition; 1.2. Scope of the Market; 1.2.1. Markets Covered.; 1.2.2. Years Considered for Study; 1.2.3. Key Market Segmentations
2. Research Methodology: 2.1. Objective of the Study; 2.2. Baseline Methodology; 2.3. Key Industry Partners; 2.4. Major Association and Secondary Sources; 2.5. Forecasting Methodology; 2.6. Data Triangulation & Validation; 2.7. Assumptions and Limitations
3. Executive Summary: 3.1. Overview of the Market; 3.2. Overview of Key Market Segmentations; 3.3. Overview of Key Market Players; 3.4. Overview of Key Regions/Countries; 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Label-free Array Systems Market Outlook.: 5.1. Market Size & Forecast; 5.1.1. By Value; 5.2. Market Share & Forecast; 5.2.1. By Type (surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others); 5.2.2. By Application (Drug Discovery, Protein Interface Analysis, Antibody Characterization and Others); 5.2.3. By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institute, Contract Research Organization and Others); 5.2.4. By Company (2022); 5.2.5. By Region; 5.3. Product Market Map
6. Asia-Pacific Global Label-free Array Systems Market Outlook: 6.1. Market Size & Forecast; 6.1.1. By Value; 6.2. Market Share & Forecast; 6.2.1. Type; 6.2.2. Application; 6.2.3. End user; 6.2.4. By Country; 6.3. Asia-Pacific: Country Analysis; 6.3.1. China Global Label-free Array Systems Market Outlook.; 6.3.1.1. Market Size & Forecast; 6.3.1.1.1. By Value; 6.3.1.2. Market Share & Forecast; 6.3.1.2.1. Type; 6.3.1.2.2. Application; 6.3.1.2.3. End user; 6.3.2. India Global Label-free Array Systems Market Outlook.; 6.3.2.1. Market Size & Forecast; 6.3.2.1.1. By Value; 6.3.2.2. Market Share & Forecast; 6.3.2.2.1. Type; 6.3.2.2.2. Application; 6.3.2.2.3. End user; 6.3.3. South Korea Global Label-free Array Systems Market Outlook; 6.3.3.1. Market Size & Forecast; 6.3.3.1.1. By Value; 6.3.3.2. Market Share & Forecast; 6.3.3.2.1. Type; 6.3.3.2.2. Application; 6.3.3.2.3. End user; 6.3.4. Japan Global Label-free Array Systems Market Outlook; 6.3.4.1. Market Size & Forecast; 6.3.4.1.1. By Value; 6.3.4.2. Market Share & Forecast; 6.3.4.2.1. Type; 6.3.4.2.2. Application; 6.3.4.2.3. End user; 6.3.5. Australia Global Label-free Array Systems Market Outlook; 6.3.5.1. Market Size & Forecast; 6.3.5.1.1. By Value; 6.3.5.2. Market Share & Forecast; 6.3.5.2.1. Type; 6.3.5.2.2. Application; 6.3.5.2.3. End user
7. Europe Global Label-free Array Systems Market Outlook: 7.1. Market Size & Forecast; 7.1.1. By Value; 7.2. Market Share & Forecast; 7.2.1. Type; 7.2.2. Application; 7.2.3. End user; 7.2.4. By Country; 7.3. Europe: Country Analysis; 7.3.1. France Global Label-free Array Systems Market Outlook; 7.3.1.1. Market Size & Forecast; 7.3.1.1.1. By Value; 7.3.1.2. Market Share & Forecast; 7.3.1.2.1. Type; 7.3.1.2.2. Application; 7.3.1.2.3. End user; 7.3.2. Germany Global Label-free Array Systems Market Outlook; 7.3.2.1. Market Size & Forecast; 7.3.2.1.1. By Value; 7.3.2.2. Market Share & Forecast; 7.3.2.2.1. Type; 7.3.2.2.2. Application; 7.3.2.2.3. End user; 7.3.3. United Kingdom Global Label-free Array Systems Market Outlook; 7.3.3.1. Market Size & Forecast; 7.3.3.1.1. By Value; 7.3.3.2. Market Share & Forecast; 7.3.3.2.1. Type; 7.3.3.2.2. Application; 7.3.3.2.3. End user; 7.3.4. Italy Global Label-free Array Systems Market Outlook; 7.3.4.1. Market Size & Forecast; 7.3.4.1.1. By Value; 7.3.4.2. Market Share & Forecast; 7.3.4.2.1. Type; 7.3.4.2.2. Application; 7.3.4.2.3. End user; 7.3.5. Spain Global Label-free Array Systems Market Outlook; 7.3.5.1. Market Size & Forecast; 7.3.5.1.1. By Value; 7.3.5.2. Market Share & Forecast; 7.3.5.2.1. Type; 7.3.5.2.2. Application; 7.3.5.2.3. End user
8. North America Humic-based bio stimulants Market Outlook.: 8.1. Market Size & Forecast; 8.1.1. By Value; 8.2. Market Share & Forecast; 8.2.1. Type; 8.2.2. Application; 8.2.3. End user; 8.2.4. By Country; 8.3. North America: Country Analysis; 8.3.1. United States Global Label-free Array Systems Market Outlook; 8.3.1.1. Market Size & Forecast; 8.3.1.1.1. By Value; 8.3.1.2. Market Share & Forecast; 8.3.1.2.1. Type; 8.3.1.2.2. Application; 8.3.1.2.3. End user; 8.3.2. Mexico Global Label-free Array Systems Market Outlook; 8.3.2.1. Market Size & Forecast; 8.3.2.1.1. By Value; 8.3.2.2. Market Share & Forecast; 8.3.2.2.1. Type; 8.3.2.2.2. Application; 8.3.2.2.3. End user; 8.3.3. Canada Global Label-free Array Systems Market Outlook; 8.3.3.1. Market Size & Forecast; 8.3.3.1.1. By Value; 8.3.3.2. Market Share & Forecast; 8.3.3.2.1. Type; 8.3.3.2.2. Application; 8.3.3.2.3. End user
9. South America Global Label-free Array Systems Market Outlook: 9.1. Market Size & Forecast; 9.1.1. By Value; 9.2. Market Share & Forecast; 9.2.1. Type; 9.2.2. Application; 9.2.3. End user; 9.2.4. By Country; 9.3. South America: Country Analysis; 9.3.1. Brazil Global Label-free Array Systems Market Outlook; 9.3.1.1. Market Size & Forecast; 9.3.1.1.1. By Value; 9.3.1.2. Market Share & Forecast; 9.3.1.2.1. Type; 9.3.1.2.2. Application; 9.3.1.2.3. End user; 9.3.2. Argentina Global Label-free Array Systems Market Outlook; 9.3.2.1. Market Size & Forecast; 9.3.2.1.1. By Value; 9.3.2.2. Market Share & Forecast; 9.3.2.2.1. Type; 9.3.2.2.2. Application; 9.3.2.2.3. End user; 9.3.3. Colombia Global Label-free Array Systems Market Outlook; 9.3.3.1. Market Size & Forecast; 9.3.3.1.1. By Value; 9.3.3.2. Market Share & Forecast; 9.3.3.2.1. Type; 9.3.3.2.2. Application; 9.3.3.2.3. End user
10. Middle East and Africa Global Label-free Array Systems Market Outlook: 10.1. Market Size & Forecast; 10.1.1. By Value; 10.2. Market Share & Forecast; 10.2.1. Type; 10.2.2. Application; 10.2.3. End user; 10.2.4. By Country; 10.3. MEA: Country Analysis; 10.3.1. South Africa Global Label-free Array Systems Market Outlook; 10.3.1.1. Market Size & Forecast; 10.3.1.1.1. By Value; 10.3.1.2. Market Share & Forecast; 10.3.1.2.1. Type; 10.3.1.2.2. Application; 10.3.1.2.3. End user; 10.3.2. Saudi Arabia Global Label-free Array Systems Market Outlook; 10.3.2.1. Market Size & Forecast; 10.3.2.1.1. By Value; 10.3.2.2. Market Share & Forecast; 10.3.2.2.1. Type; 10.3.2.2.2. Application; 10.3.2.2.3. End user; 10.3.3. UAE Global Label-free Array Systems Market Outlook; 10.3.3.1. Market Size & Forecast; 10.3.3.1.1. By Value; 10.3.3.2. Market Share & Forecast; 10.3.3.2.1. Type; 10.3.3.2.2. Application; 10.3.3.2.3. End user; 10.3.4. Kuwait Global Label-free Array Systems Market Outlook; 10.3.4.1. Market Size & Forecast; 10.3.4.1.1. By Value; 10.3.4.2. Market Share & Forecast; 10.3.4.2.1. Type; 10.3.4.2.2. Application; 10.3.4.2.3. End user
11. Market Dynamics: 11.1. Drivers; 11.2. Challenges
12. Market Trends & Developments: 12.1. Recent Developments; 12.2. Mergers & Acquisitions; 12.3. Product Developments
13. Competitive Landscape: 13.1. Business Overview; 13.2. Company Snapshot; 13.3. Products & Services; 13.4. Financials (In case of listed companies); 13.5. Recent Developments; 13.6. SWOT Analysis; 13.6.1. Illumina, Inc.; 13.6.2. Thermo Fisher Scientific, Inc.; 13.6.3. Agilent Technologies, Inc.; 13.6.4. PerkinElmer, Inc.; 13.6.5. Merck KGaA; 13.6.6. Danaher Corporation; 13.6.7. Bio-Rad Laboratories, Inc.; 13.6.8. F. Hoffmann-La Roche AG; 13.6.9. Becton, Dickinson and Company; 13.6.10. Sartorius AG
14. Strategic Recommendations